Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Efficient cobalt-catalyzed C-H activation for indole carboxamides. Reduces cost and improves supply chain reliability for pharma intermediates.
Patent CN102766092A details a mild chiral spiro phosphoric acid catalyzed synthesis of optically active tetrahydroquinolines, offering high enantioselectivity and simplified purification for API manufacturing.
Patent CN111978194B details a novel Pd-catalyzed carbonylation using benzyl formate. Offers cost-effective, scalable routes for pharmaceutical intermediates.
Patent CN113980044B details a novel Ir-O-P catalyzed C-H borylation method offering high yields and broad substrate scope for pharmaceutical intermediates.
Novel quinoline-substituted ligand enables high ee asymmetric trifluoromethylation. Cost-effective synthesis for pharmaceutical intermediate manufacturing supply chain.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method yielding high-purity axially chiral oxindole-substituted styrenes for asymmetric catalysis applications.
Novel chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-substituted styrenes. High ee values up to 96%. Ideal for pharma intermediates.
Novel synthesis of axial chiral cyclopentenyl indole-naphthyl compounds via chiral phosphoric acid. High enantioselectivity and cytotoxic activity for pharmaceutical applications.
Patent CN108026017B reveals a novel tetraalkylammonium-catalyzed method for producing acid halide solutions, enabling cost reduction in electronic chemical manufacturing and high-purity intermediates.
Novel axial chiral bisindole catalysts for asymmetric synthesis. Superior stereoselectivity and mild conditions for pharmaceutical intermediates manufacturing.
This patent introduces a novel dual-chiral ligand enabling high enantioselectivity in asymmetric catalysis, offering significant cost reduction and supply chain reliability for API intermediates manufacturing.
This patent reveals a novel visible-light-driven iron-catalyzed method for aryl benzyl sulfide synthesis, offering enhanced substrate scope and milder conditions for reliable pharmaceutical intermediate production.
Patent CN113307778A enables mild-condition synthesis of 3-trifluoromethyl triazoles with high efficiency and scalable production for pharmaceutical supply chains.
Patent CN109867658B enables efficient production of diverse aminothiophene derivatives through mild phase transfer catalysis, offering significant cost reduction and enhanced supply chain reliability for pharmaceutical manufacturing.
Patent CN103254250B introduces a high-efficiency palladium-NHC catalyst enabling mild synthesis of bis(trifluoromethyl) biaryl compounds with broad substrate scope, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
This patent introduces a novel metal-free triazole synthesis method eliminating anhydrous conditions and heavy metal catalysts while ensuring high purity and scalable production for pharmaceutical intermediates.
Novel palladium-catalyzed process enables high-yield branched allyl compound production with simplified supply chain and reduced manufacturing costs.
Patent CN113735867B introduces mild room temperature synthesis of chiral indolo-oxa compounds with high yield and enantioselectivity offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing
This patent introduces a novel halogen bond-catalyzed method for five-membered oxygen heterocyclic compounds offering metal-free synthesis high selectivity and mild conditions enhancing supply chain reliability for pharma manufacturers
Novel nitrate hydrate-based method enables cost-effective production of high-purity geminal dinitro compounds with enhanced scalability for pharmaceutical applications.